Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.
Post-Market Drug Surveillance
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Read more: Big Data and Pharmacovigilance, Part II Big Data and Pharmacovigilance, Part II
By Dov Fox Yesterday, I wrote about Ryan Abbott‘s new article that proposes to use health information exchanges to improve the collection of data about the safety of approved drugs. Today, I want to address his recommendation that the government pay private parties to help the Food and Drug Administration conduct post-market drug surveillance. The article argues that health information…